Search

Author/Creator Foltz, Lynda

1. Analysis of predictors of response to ruxolitinib in patients with myelofibrosis in the phase 3b expanded-access JUMP study. Issue 4 (21st March 2021)

Authors:
Gupta, Vikas; Griesshammer, Martin; Martino, Bruno; Foltz, Lynda; Tavares, Renato; Al-Ali, Haifa Kathrin; Giraldo, Pilar; Guglielmelli, Paola; Lomaia, Elza; Bouard, Catherine; Paley, Carole; Tiwari, Ranjan; Zor, Evren; Raanani, Pia
Journal:
Leukemia & lymphoma
Issue:
Volume 62:Issue 4(2021)
Page Start:
918
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Comparing the safety and efficacy of ruxolitinib in patients with Dynamic International Prognostic Scoring System low‐, intermediate‐1‐, intermediate‐2‐, and high‐risk myelofibrosis in JUMP, a Phase 3b, expanded‐access study. Issue 4 (5th July 2021)

Authors:
Passamonti, Francesco; Gupta, Vikas; Martino, Bruno; Foltz, Lynda; Zaritskey, Andrey; Al‐Ali, Haifa Kathrin; Tavares, Renato; Maffioli, Margherita; Raanani, Pia; Giraldo, Pilar; Griesshammer, Martin; Guglielmelli, Paola; Bouard, Catherine; Paley, Carole; Tiwari, Ranjan; Vannucchi, Alessandro M.
Journal:
Hematological oncology
Issue:
Volume 39:Issue 4(2021)
Page Start:
558
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study. Issue 10373 (28th January 2023)

Authors:
Verstovsek, Srdan; Gerds, Aaron T; Vannucchi, Alessandro M; Al-Ali, Haifa Kathrin; Lavie, David; Kuykendall, Andrew T; Grosicki, Sebastian; Iurlo, Alessandra; Goh, Yeow Tee; Lazaroiu, Mihaela C; Egyed, Miklos; Fox, Maria Laura; McLornan, Donal; Perkins, Andrew; Yoon, Sung-Soo; Gupta, Vikas; Kilad...
Journal:
Lancet
Issue:
Volume 401:Issue 10373(2023)
Page Start:
269
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Perioperative management of myeloproliferative neoplasms: A pan‐Canadian physician survey and international expert opinion. Issue 12 (3rd October 2022)

Authors:
Szuber, Natasha; Toliopoulos, Panagiota; Busque, Lambert; Cerquozzi, Sonia; Foltz, Lynda; Gupta, Vikas; Tefferi, Ayalew; Vannucchi, Alessandro Maria; Hillis, Christopher; Leber, Brian; Maze, Dawn; Prchal, Jaroslav; Olney, Harold J.; Sirhan, Shireen
Journal:
American journal of hematology
Issue:
Volume 97:Issue 12(2022)
Page Start:
E466
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Primary analysis of JUMP, a phase 3b, expanded‐access study evaluating the safety and efficacy of ruxolitinib in patients with myelofibrosis, including those with low platelet counts. (4th February 2020)

Authors:
Al‐Ali, Haifa Kathrin; Griesshammer, Martin; Foltz, Lynda; Palumbo, Giuseppe A.; Martino, Bruno; Palandri, Francesca; Liberati, Anna Marina; le Coutre, Philipp; García‐Hernández, Carmen; Zaritskey, Andrey; Tavares, Renato; Gupta, Vikas; Raanani, Pia; Giraldo, Pilar; Hänel, Mathias; Damiani, Danie...
Journal:
British journal of haematology
Issue:
Volume 189:Number 5(2020)
Page Start:
888
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Safety and efficacy findings from the open-label, multicenter, phase 3b, expanded treatment protocol study of ruxolitinib for treatment of patients with polycythemia vera who are resistant/intolerant to hydroxyurea and for whom no alternative treatments are available. Issue 14 (6th December 2019)

Authors:
Foltz, Lynda; Pica, Gian-Matteo; Zerazhi, Hacene; Van Droogenbroeck, Jan; Visanica, Sorin; Báez de la Fuente, Enrique; Leber, Brian; de Almeida, Antonio Medina; Ranta, Dana; Kiladjian, Jean-Jacques; Chrit, Linda; Kandra, Albert; Morando, Juliane; Devos, Timothy
Journal:
Leukemia & lymphoma
Issue:
Volume 60:Issue 14(2019)
Page Start:
3493
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗